Influence of Telemonitoring on the Management of LVAD-patients

University Hospital Essen

Status: Unknown

Conditions: Ventricular Assist Device; Heart Failure; Telemedicine

Treatments: Other: questionnaire (observational study)

Study type: Observational

Funder types: Other

Identifiers

NCT04613401

20-9312-BO

Details and patient eligibility

About

The current study aims to investigate whether telemedical monitoring in patients with terminal heart failure and an implanted left ventricular assist device (LVAD) has an influence on LVAD-associated complications, hospitalization rates and quality of life. This is a prospective observational study. Patients with terminal heart failure and an implanted LVAD, where the indication for telemonitoring has already been stated by the attending physician are included in the study. Written informed consent is obtained from all patients. The telemedical monitoring is carried out by the West German Center for Applied Telemedicine (WZAT) and includes a standardized telephone interview every 3 days. In addition, all patients are equipped with an INR measuring device, a body scale and a clinical thermometer by WZAT. The data is documented in an electronic case file (medPower®). In the event of abnormalities, the West German Heart and Vascular Center (WHGZ) is contacted, and all necessary measures are initiated.

Enrollment: 50 estimated patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age> 18 years
• Indication for telemedicine
• Permanently implanted left ventricular assist device (VAD)

Exclusion criteria

• no possibility of telephone contact
• patient does not speak german
• incompliance
• rejection or inability to give consent

Trial design

50 participants in 1 patient group

VAD-patients with Telemonitoring

Treatment:

Other: questionnaire (observational study)